RISPERIDON Mepha LA subst sèche 50 mg c solv
7680676220037
CH-67622
N05AX08
01.05.0.
1 / 3
google
Details
- Product number
- 6762203
- CPT
- -
- Packaging group
- 1
- Unit
- Set
- Composition
- Praeparatio sicca: risperidonum 50 mg, poly(lactidum-co-glycolidum). Solvens: carmellosum natricum, polysorbatum 20, dinatrii phosphas dihydricus, acidum citricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml, pro vase, in suspensione recenter reconstituta corresp. natrium 10.863 mg.
Articles (1)
Risperidon-Mepha LA 50 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur i.m. Injektion
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
- | Substance | HNIDK |
|
PRS
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
10.863 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 149.90
Specialties list
Yes
Generic
Yes
SL addition date:
01/11/2022
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67622
- Drug name
- Risperidon-Mepha LA, Pulver und Lösungsmittel zur Herstellung einer Suspension zur i.m. Injektion
- Galenic form
- PULVS
- ATC Code
- N05AX08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 13/08/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RISPERIDON Mepha LA subst sèche 50 mg c solv
- Description (DE)
- RISPERIDON Mepha LA Trockensub 50 mg c Solv
- Market launch
- 13/08/2020
- Narcotic (BTM)
- No